January 5, 2012 - Ontario, Canada - Intertek Cantox, a leading provider of scientific and regulatory consulting services to the food, chemical, and pharmaceutical industries, announces the development of a method to promote high quality nanotoxicology studies allowing companies to ensure the safety of nanotechnology-based products entering the market. With increasing interest in the use of nanomaterials in a wide variety of industries, the number of published studies on the safety of nanomaterials continues to grow. During the Materials Research Society meeting held in November 2011, Dr. Jeffrey Card, Senior Program Manager in Toxicology at Intertek presented on the evaluation of the published literature on the safety of oral exposure to nanomaterials.
- Intertek Cantox
November 22, 2011 - Ontario, Canada - Intertek Cantox, a leading provider of risk assessment and regulatory support solutions and serving a wide range of industries around the world, today announced the expansion of exposure assessment capabilities through the addition of CREMe (Central Risk & Exposure Modelling e-solution) software to their current service offerings.
- Intertek Cantox
October 17, 2011 - Ontario, Canada - Intertek Cantox, a leading provider of scientific and regulatory consulting services, today announced its plans to bring China IECSC Chemical Notification expert, Ms. Amy Lee of Shanghai, to the Toronto area to deliver important updates on China’s new chemicals notification program administered under China's State Environmental Protection Administration's Chemical Registration Center (SEPA CRC), including the authority’s intent to close the door on industry’s opportunity to add substances to the Inventory of Existing Chemical Substances in China (IECSC). Substances listed on the IECSC are exempt from the need for pre-market approval under China’s New Chemicals Notification law.
- Intertek Cantox
[Click Here for Additional Press Releases]
Webinar Q&A—Intertek on Compliance with EU Cosmetic Regulations
December 7, 2011 - Intertek's webinar, "Compliance With the New European Union Cosmetics Regulations – Are You Ready for 2013?", presented by David H. Bechtel, Ph.D., DABT, VP, New Jersey; and Andrea W. Wong, Ph.D., senior scientific & regulatory consultant, discussed what actions the cosmetic industry must take into comply with the new regulation. Inside Cosmeceuticals was able to ask Intertek a few questions in addition to the information it provided in the free webinar.
- Inside Cosmeceuticals
Nano rules fall foul of data gap
December 6, 2011 - Intertek Cantox Nano toxicology experts were recently acknowledge in an article by Nature International Weekly Journal of Science to address the Incomplete nanotoxicology research that is hampering efforts to introduce regulation.
- Intertek Cantox
Could conditions of use condemn health claim victories?
November 21, 2011 - In recent months the European Food Safety Authority (EFSA) has come under increasing pressure to moderate its scientific approach to the assessment of health claims from parts of the industry and the academic community.
- NutraIngredients
Are Nanoparticles in Sunscreens a Big Deal?
October 5, 2011 - As we wrap up the topic of sunscreens, we end with a post on nanoparticles: a big debate over something so small. Proponents of the technology sing the praises that nanoparticles help get rid of the old school pasty white effect of sunscreens passed, which is no doubt a hit with today's consumers. But do these particles penetrate the skin and cause possible damage? Read on for insight from Intertek Cantox's Jeffrey Card, Ph.D., Senior Program Manager, Toxicology Pharmaceuticals and Healthcare.
- SupplySide
[Click Here for Additional Articles]
Pulmonary Applications and Toxicity of Engineered Nanoparticles.
Card JW, Zeldin DC, Bonner JC, Nestmann ER.
Because of their unique physicochemical properties, engineered nanoparticles have the potential to significantly impact respiratory research and medicine by means of improving imaging capability and drug delivery, among other applications. These same properties, however, present potential safety concerns, and there is accumulating evidence to suggest that nanoparticles may exert adverse effects on pulmonary structure and function. The respiratory system is susceptible to injury resulting from inhalation of gases, aerosols, and particles, and also from systemic delivery of drugs, chemicals, and other compounds to the lungs via direct cardiac output to the pulmonary arteries. As such, it is a prime target for the possible toxic effects of engineered nanoparticles. The purpose of this article is to provide an overview of the potential usefulness of nanoparticles and nanotechnology in respiratory research and medicine and to highlight important issues and recent data pertaining to nanoparticle-related pulmonary toxicity.
Proposed Minimum Characterization Parameters for Studies on Food and Food-Related Nanomaterials.
Card JW, Magnuson BA.
J Food Sci. 2009 Oct;74(8):vi-vii. PubMed
PMID: 19799686.
[Click Here for Additional Publications]


Are you in compliance with the regulations affecting cosmetic products?
For more information ...
Intertek Cantox Opens an Office in Beijing, China.
[more info]
Don't Miss our Workshop on the Regulation of Animal Feed Ingredients in the United States.
[more info]
Learn more about the Environmental Assessment Regulations and the In-Commerce List for Food & Drug Act Substances and how our services can help support your company’s business interests.
[more info]
If your company has been notified of a violation of the California Prop 65 law for your products, we offer a variety of services that may helpful in responding to this notice.
[more info]
Cantox is pleased to offer expertise in Nanotechnology and Veterinary Nutraceuticals.
![]()
![]()